持分法適用会社への投資額 - その他、株主資本以外の項目の当期変動額（純額）、全事業営業利益又は全事業営業損失（△） - オセアニア他2件
- 【期間】
| 年度 | 持分法適用会社への投資額 - その他 | 株主資本以外の項目の当期変動額（純額） | 全事業営業利益又は全事業営業損失（△） - オセアニア | のれん - 医薬・バイオケミカル | 現金及び現金同等物の期首残高 |
|---|
| 2008/12 | - | | 162百万 | | - | | - | | 685億 | |
| 2009/12 | - | | 33百万 | -79.6% | - | | - | | 1188億 | +73.5% |
| 2010/12 | - | | 11百万 | -66.7% | - | | - | | 453億 | -61.9% |
| 2011/03 | - | | - | | - | | - | | 1862億 | +311.2% |
| 2011/06 | - | | - | | - | | - | | 560億 | -69.9% |
| 2011/09 | - | | - | | - | | - | | 811億 | +44.8% |
| 2011/12 | - | | 42百万 | +281.8% | - | | - | | 708億 | -12.6% |
| 2012/06 | - | | - | | - | | - | | 593億 | -16.4% |
| 2012/12 | 39.9億 | | -47百万 | 赤転 | 206億 | | 1250億 | | 780億 | +31.7% |
| 2013/03 | - | | - | | 113億 | -44.8% | - | | - | |
| 2013/06 | - | | - | | 200億 | +76.1% | - | | 421億 | -46% |
| 2013/09 | - | | - | | 232億 | +15.9% | - | | - | |
| 2013/12 | 5.03億 | -87.4% | - | | 288億 | +24.3% | 1228億 | -1.8% | 1055億 | +150.3% |
| 2014/03 | - | | - | | 149億 | -48.2% | - | | - | |
| 2014/06 | - | | - | | 217億 | +45.1% | - | | 344億 | -67.4% |
| 2014/09 | - | | - | | 236億 | +9.1% | - | | - | |
| 2014/12 | 4.93億 | -2% | - | | 276億 | +16.7% | 1352億 | +10.1% | 407億 | +18.5% |
| 2015/03 | - | | - | | 176億 | -36.4% | - | | - | |
| 2015/06 | - | | - | | 287億 | +63.3% | - | | 197億 | -51.7% |
| 2015/09 | - | | - | | 363億 | +26.8% | - | | - | |
| 2015/12 | 1.92億 | -61.1% | - | | 481億 | +32.3% | 1178億 | -12.9% | 603億 | +206.6% |
| 2016/03 | - | | - | | 171億 | -64.5% | - | | - | |
| 2016/06 | - | | - | | 253億 | +47.9% | - | | 571億 | -5.3% |
| 2016/09 | - | | - | | 315億 | +24.6% | - | | - | |
| 2016/12 | - | | - | | 428億 | +36.1% | 999億 | -15.1% | 577億 | +1.1% |
| 2017/03 | - | | - | | 129億 | -69.8% | - | | - | |
| 2017/06 | - | | - | | 208億 | +60.9% | - | | 1663億 | +188% |
| 2017/09 | - | | - | | 280億 | +34.9% | - | | - | |
| 2018/12 | - | | - | | - | | - | | - | |
| 2019/12 | - | | - | | - | | - | | - | |
| 2020/03 | - | | - | | - | | - | | - | |
| 2020/06 | - | | - | | - | | - | | - | |
| 2020/09 | - | | - | | - | | - | | - | |
| 2020/12 | - | | - | | - | | - | | - | |
| 2021/03 | - | | - | | - | | - | | - | |
| 2021/06 | - | | - | | - | | - | | - | |
| 2021/09 | - | | - | | - | | - | | - | |
| 2021/12 | - | | - | | - | | - | | - | |
| 2022/03 | - | | - | | - | | - | | - | |
| 2022/06 | - | | - | | - | | - | | - | |
| 2022/09 | - | | - | | - | | - | | - | |
| 2022/12 | - | | - | | - | | - | | - | |
| 2023/03 | - | | - | | - | | - | | - | |
| 2023/06 | - | | - | | - | | - | | - | |
| 2023/09 | - | | - | | - | | - | | - | |
| 2023/12 | - | | - | | - | | - | | - | |
| 2024/03 | - | | - | | - | | - | | - | |
| 2024/06 | - | | - | | - | | - | | - | |
